spondyloarthropathy

(redirected from Spondylarthropathy)
Also found in: Encyclopedia.

spondyloarthropathy

 [spon″dĭ-lo-ahr-throp´ah-the]
disease of the joints of the spine.

spondyloarthropathy

(spŏn′dl-ō-är-thrŏp′ə-thē)
n.
Any of several diseases of the joints of the spine.

spondyloarthropathy

[spon′dilō′ärthrop′əthē]
any of a set of diseases of the joints and spine. Most commonly affected are the lower extremities, sacroiliac joint, and hip. Pain and restricted motion of the hips and lower back are typical complaints. Many patients also experience eye disorders.

spondyloarthropathy

vertebral joint disease; characteristic of spondylitis

spondyloarthropathy

disease of the joints of the spine.

Patient discussion about spondyloarthropathy

Q. Our GP said that I have a greater risk for joint disease because I am HLA-B27 + . what is he talking about? My mom and dad have a spondyloarthropathy. they went to our GP and he did us some genetic tests and said that I am HLA-B27 positive, and that i have a greater risk for several diseases. what kind of diseases is he talking about?

A. HLA-B27 is a part of our immune system. Some of us )like me) have this gene and some of us don't have it. The fact you have this gene says you might have some diseases.
Those diseases are mainly arthritis for its kinds and inflammatory bowel diseases (witch I have and its totally manageable.
if your parents have only spondyloarthropathy I guess you can expect you will have a spondyloarthropathy too.
Go to your GP and ask him to explain you more about this.

More discussions about spondyloarthropathy
References in periodicals archive ?
Involvement of matrix metalloproteinases and their inhibitors in peripheral synovitis and down-regulation by tumor necrosis factor alpha blockade in spondylarthropathy.
HLA-B-27 subtypes in Turkish patients with spondylarthropathy and healthy controls.
Da Costa, Dritsa, Ring, and Fitzcharles (2004) found an association between more physical leisure time activities and decreased fatigue in 66 people with spondylarthropathy.
Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy.
Outcome and predictive factors in juvenile rheumatoid arthritis and juvenile spondylarthropathy.
Corticosteroid injection of the sacroiliac joint in patients with seronegative spondylarthropathy.
4) Psoriatic spondylarthropathy (HLA-B27+) 11 Negative SSA (23.
A hidradenitis suppurativa related SAPHO case associated with features resembling spondylarthropathy and proteinuria.
Other diseases and conditions that are reported to cause increased pyridinium cross-links concentrations are liver dysfunction (144), renal osteodystrophy (153), Camurati-Engelmann disease (146), spinal cord injury (147), bone marrow transplantation (148), gastrointestinal diseases related to nutrition and mineral metabolism (149), cystic fibrosis (150), scleroderma (151), growth hormone/receptor deficiencies and other growth disorders, growth hormone treatment (152), hyperprolactinemia in amenorrheic patients with estrogen deficiency (153), myelomeningocele (154), and seronegative spondylarthropathy (155).